A positron-emission tomography study to determine brain exposure of [11C]savolitinib in healthy volunteers

Trial Identifier:	D5084C00016
Sponsor:	AstraZeneca
NCTID::	NCT06348355
Start Date:	April 2024
Primary Completion Date:	June 2024
Study Completion Date:	June 2024
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
SE	Solna, SE, 171 64

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.